Tech Company Financing Transactions
Synosia Therapeutics Funding Round
5AM Ventures and Versant Ventures participated in a $10 million capital raise for Synosia Therapeutics. The round was announced by the company on 12/31/2007.
Transaction Overview
Company Name
Announced On
12/31/2007
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
5AM Ventures (Andrew Schwab)
Versant Ventures (Bradley Bolzon)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
601 Gateway Boulevard 1200
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Synosia Therapeutics is a drug development company focused on finding innovative treatments for disorders of the central nervous system (CNS). We are leading a new approach in CNS, establishing a better understanding of a drug's action earlier in development than ever before through small, smart clinical trials.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ian Massey
Chief Financial Officer
Philippe Lutz
Chief Medical Officer
Steve Bandak
Vice President
Lesley Pickford
VP - Bus. Development
Tom Woiwode
VP - Finance
Zachary Mcnealy
VP - Operations
Thomas Malefyt
VP - Operations
Ann Neale
VP - R & D
Uwe Meya
VP - Regulatory Affairs
Michael Elson
Browse more venture capital transactions:
Prev: 12/31/2007: TiVaMed venture capital transaction
Next: 12/31/2007: Eden Park Illumination venture capital transaction
Share this article
About Database of VC Transactions
We report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs